517312
Anti-P-Glycoprotein Mouse mAb (C494)
liquid, clone C494, Calbiochem®
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12352203
Clone:
C494, monoclonal
Species reactivity:
human, hamster
Application:
—
Citations:
3
biological source
mouse
Quality Level
antibody form
purified antibody
antibody product type
primary antibodies
clone
C494, monoclonal
form
liquid
contains
≤0.1% sodium azide as preservative
species reactivity
human, hamster
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, avoid repeated freeze/thaw cycles
isotype
IgG2a
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
General description
Purified mouse monoclonal antibody. Recognizes the ~170 kDa MDR1 isoform of P-glycoprotein.
Recognizes the ~170 kDa MDR1 isoform of P-glycoprotein. Does not cross-react with the MDR3 P-glycoprotein.
This Anti-P-Glycoprotein Mouse mAb (C494) is validated for use in Paraffin Sections, FC, Frozen Sections, Immunoblotting, ICC, IP for the detection of P-Glycoprotein.
Immunogen
Epitope: gene-specific internal cellular epitope present only on the MDR1 isoform of P-glycoprotein
Hamster and Human
SDS-solubilized plasma membranes of a multidrug resistant (MDR) Chinese hamster ovary (CHO) cell line and a human leukemic cell line
Application
Paraffin Sections (5-10 µg/ml, see comments)
Flow Cytometry (see comments)
Frozen Sections (5-10 µg/ml, see comments)
Immunoblotting (see comments)
Immunocytochemistry (see application references)
Immunoprecipitation (see comments)
Flow Cytometry (see comments)
Frozen Sections (5-10 µg/ml, see comments)
Immunoblotting (see comments)
Immunocytochemistry (see application references)
Immunoprecipitation (see comments)
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In PBS, 1% BSA.
Preparation Note
Following initial thaw, aliquot and freeze (-20°C).
Analysis Note
Positive Control
Cell lines or frozen tissue, such as human liver or colon.
Cell lines or frozen tissue, such as human liver or colon.
Other Notes
Does not cross-react with MDR3 P-glycoprotein. Also reported to work for flow cytometry, immunoblotting, and immunoprecipitation. For immunocytochemistry, frozen or paraffin-embedded material may be used. Permeabilization of the cell membrane is required to expose the epitope recognized by this antibody. Variables associated with assay conditions will dictate the proper working dilutions.
Rao, V.V., et al. 1994. Cancer Res.54, 1536.
Toth, K., et al. 1992. Am. J. Pathol.140, 1009.
Georges, E., et al. 1990. Proc. Natl. Acad. Sci. USA87, 152.
Toth, K., et al. 1992. Am. J. Pathol.140, 1009.
Georges, E., et al. 1990. Proc. Natl. Acad. Sci. USA87, 152.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
Still not finding the right product?
Try our Product Selector Tool to narrow your options
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Regino Mercado-Lubo et al.
Nature communications, 7, 12225-12225 (2016-07-28)
Salmonella enterica serotype Typhimurium is a food-borne pathogen that also selectively grows in tumours and functionally decreases P-glycoprotein (P-gp), a multidrug resistance transporter. Here we report that the Salmonella type III secretion effector, SipA, is responsible for P-gp modulation through
Amélie Petitprez et al.
International journal of oncology, 42(5), 1644-1653 (2013-04-03)
Irinotecan is a major anticancer agent specifically targeting DNA topoisomerase I. Its cytotoxicity is mediated via a two-step process involving accumulation of reversible DNA‑topoisomerase I complexes associated with transient DNA single-strand breaks which subsequently are converted into permanent DNA double-strand
Golam Kibria et al.
Biological & pharmaceutical bulletin, 37(12), 1926-1935 (2014-12-03)
Multi-drug resistance (MDR) of cancers to chemotherapy including doxorubicin (DOX) is mediated by several factors. To design an effective therapy for the treatment of chemotherapy-resistant cancers, it is essential to explore the elements responsible for mediating MDR. However, exploring these